US Health Regulators Nod to Merck Diabetes-Cholesterol Combined Pill

In a commendable effort, Merck & Co has managed to get a green signal from the US health regulators for a joint pill for all those who are suffering with health concerns of diabetes and high cholesterol.

While the news is getting the much deserved attention from medical fraternity across the world, it’s being believed that Juvisync would become a sure shot hit in the market and sales figures would be worth appreciating.

It’s being claimed that the pill would have same effects of that being obtained from drug maker’s diabetes medicine Januvia, along with simvastatin.  Read More

Posted in: Health